SYNTHACE LIMITED
Company number 07652459 · Active · London W12 7FQ
SYNTHACE LIMITED is an active private limited company (company number 07652459) incorporated on 31 May 2011, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest group accounts cover the period ending 31 January 2025, showing net assets of −£8.93m and cash of £368k, with 54 employees on average. Net assets fell 1747% on the prior period (−£483k). Across the last 3 periods on record the net-asset trend is falling.
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
Key dates
- Incorporated
- 31 May 2011
- Next accounts due
- 31 October 2026 — in 9 days
- Confirmation statement due
- 14 June 2027 — in 235 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Group
- Size band
- Micro (Companies Act thresholds)
Financials — 4 periods on record, latest ending 31 January 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 January 2025 | −£8.93m | £368k | £1.90m | — | — | −£9.41m | 54 |
| 31 January 2024 | −£483k | £3.87m | £1.85m | — | — | −£11.89m | 61 |
| 31 January 2023 | £10.37m | £10.72m | £2.55m | — | — | −£9.69m | 60 |
| 31 January 2022 | — | — | — | — | — | — | — |
- Cash per employee
- £6,807
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score: 44/100 (grade D)
- -15 Negative net assets — Net assets £-8,926,830 at 2025-01-31
- -8 Net assets falling — -1746.8% vs prior period
- +4 Cash reserves — Cash £367,569
- +5 Multi-year filing history — 4 periods on record
- +8 Established — Incorporated 2011-05-31 (15 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Sofinnova Crossover I Slp (corporate entity, France) — owns 25–50% of shares; holds 25–50% of voting rights · since 11 August 2025
- Sofinnova Green Seed Fund (corporate entity) — owns 25–50% of shares; holds 25–50% of voting rights · since 1 June 2016 · ceased 21 September 2017
- (persons with significant control statement) — · since 5 October 2017 · ceased 11 August 2025
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in London
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- NANOGENICS LIMITED — London, inc. May 2011
- ABIMMUNO LIMITED — London, inc. May 2011
- COLBE R&D LIMITED — London, inc. May 2011
- SYNTHESIS MED CHEM (UK) LIMITED — London, inc. May 2011
- VITAE BIOTECH LTD — London, inc. Jun 2011
- OXFORD GENETICS LTD — London, inc. Apr 2011
All companies incorporated on 31 May 2011 · in May 2011.
Reminders for SYNTHACE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.